During the past decade, Saint Vincent Consultants in Cardiovascular Diseases conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Vincent Consultants in Cardiovascular Diseases" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Saint Vincent Consultants in Cardiovascular Diseases" are "Heart Failure" (3 trials), "Acute Coronary Syndrome" (1 trials), "Arterial Occlusive Diseases" (1 trials), "Bradycardia" (1 trials) and "Critical Limb Ischemia (CLI)" (1 trials). Many other conditions were trialed in "Saint Vincent Consultants in Cardiovascular Diseases" in a lesser frequency.

Most popular intervention types in "Saint Vincent Consultants in Cardiovascular Diseases" are "Device" (8 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AL-208" (1 trials), "Apixaban" (1 trials), "CRT Patients" (1 trials) and "CRT-D System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Vincent Consultants in Cardiovascular Diseases" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Saint Vincent Consultants in Cardiovascular Diseases". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Saint Vincent Consultants in Cardiovascular Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Vincent Consultants in Cardiovascular Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".